Skip to main content

UBS Group AG

Position in HOWL — Werewolf Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in HOWL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$77,700
+$22,009 QoQ
Shares Held
215,838
+222.8% QoQ
Ownership
0.444%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 45 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in HOWL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. HOWL ranks #374 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in HOWL

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $77,700 215,838
2026-03-31 $55,691 66,857
2025-12-31 $38,488 60,708
2025-09-30 $25,168 12,776
2025-06-30 $3,747 3,438
2025-03-31 $17,192 17,688
2024-12-31 $45,128 30,493
2024-09-30 $32,815 15,479
2024-06-30 $23,931 9,808
2024-03-31 $239 37
2023-12-31 $3,860 1,000
2023-09-30 $2,140 1,000
2023-06-30 $3,050 1,000
2023-03-31 $2,600 1,000
2022-12-31 $2,967 1,448
2022-09-30 $11,049 2,450
2022-06-30 $17,411 4,257
2022-03-31 $9,253 2,103
2021-12-31 $112,656 9,459
2021-09-30 $28,125 1,639
2021-06-30 $17,440 1,000